prof. dr. E.M.D. (Ed) Schuuring

Professor of Molecular Oncological Pathology

prof. dr. E.M.D. (Ed) Schuuring
E-mail:
e.schuuring umcg.nl

Research

  1. 2020
  2. Weber, S., Spiegl, B., Perakis, S. O., Ulz, C. M., Abuja, P. M., Kashofer, K., ... Heitzer, E. (2020). Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling. Cancers, 12(6), [1588]. https://doi.org/10.3390/cancers12061588
  3. International Quality Network for Pathology ctDNA Working Group and the European Society of Pathology Foundation Assessors, Van Casteren, K., Keppens, C., Schuuring, E., Deans, Z. C., Normanno, N., ... Dequeker, E. M. C. (2020). External Quality Assessment Schemes for Biomarker Testing in Oncology: Comparison of Performance between Formalin-Fixed, Paraffin-Embedded-Tissue and Cell-Free Tumor DNA in Plasma. Journal of molecular diagnostics, 22(6), 736-747. https://doi.org/10.1016/j.jmoldx.2020.02.011
  4. van Veggel, B., Madeira R Santos, J. F. V., Hashemi, S. M. S., Paats, M. S., Monkhorst, K., Heideman, D. A. M., ... de Langen, A. J. (2020). Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer. Lung Cancer, 141, 9-13. https://doi.org/10.1016/j.lungcan.2019.12.013
  5. Innovative Medicines Initiative CANCER-ID Consortium, Lampignano, R., Neumann, M. H. D., Weber, S., Kloten, V., Herdean, A., ... Heitzer, E. (2020). Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows. Clinical Chemistry, 66(1), 149-160. https://doi.org/10.1373/clinchem.2019.306837
  6. 2019
  7. Fairley, J., Cheetham, M., Denis, M. G., Dequeker, E., Keppens, C., Fenizia, F., ... Deans, Z. C. (2019). Findings from the Global External Quality Assessment of Lung Cancer Liquid Biopsy Testing. Journal of molecular diagnostics, 21(6), 1128.
  8. Thunnissen, E., Lissenberg-Witte, B. I., van den Heuvel, M. M., Monkhorst, K., Skov, B. G., Sørensen, J. B., ... Smit, E. F. (2019). ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. Lung Cancer, 138, 13-18. https://doi.org/10.1016/j.lungcan.2019.09.023
  9. Deans, Z. C., Butler, R., Cheetham, M., Dequeker, E. M. C., Fairley, J. A., Fenizia, F., ... Patton, S. J. (2019). IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing. Virchows Archiv, 474(6), 681-689. https://doi.org/10.1007/s00428-019-02571-3
  10. Pantel, K., Terstappen, L. W. M. M., manaresi, N., Groen, H. J. M., Tamminga, M., Schuuring, E., ... Schlange, T. (2019). Standardization and clinical implementation of liquid biopsy assays - IMI's CANCER-ID. Poster session presented at AACR annual meeting 2019, Atlanta, United States.
  11. 2018
Previous 1 2 3 4 5 Next

ID: 212863